Tabouret, Emeline, 1985-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Tabouret, Emeline
Emeline Tabouret
VIAF ID: 315249563 (Personal)
Permalink: http://viaf.org/viaf/315249563
Preferred Forms
-
100 0 _
‡a
Emeline Tabouret
-
100 1 _
‡a
Tabouret, Emeline
-
100 1 _
‡a
Tabouret, Emeline,
‡d
1985-....
4xx's: Alternate Name Forms (2)
5xx's: Related Names (2)
- 510 2 _
‡a
Aix-Marseille Université
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 551 _ _
‡a
Marseille
‡4
ortw
‡4
https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
| Title | Sources |
|---|---|
| Apports de la Médecine de Précision à la Neurochirurgie : Applications aux Glioblastomes |
|
| Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma. |
|
| Biomarqueurs prédictifs de l'activité du bevacizumab chez des patients porteurs de gliomes de haut grade à la récidive |
|
| BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. |
|
| Contribution of Precision Medicine to Νeurοsurgery : Αpplicatiοns to Gliοblastomas. |
|
| Function of CIC transcription factor in oligodendrocyte and oligodendroglioma development. |
|
| glioblastoma and angiogenesis : evolutive profile, interaction with invasiveness and therapeutic implications. |
|
| Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016 |
|
| Pertinence de la réalisation systématique d'un scanner post-opératoire après craniotomie neurochirurgicale, et de son impact dans la prise en charge des patients neurochirurgicaux : à propos d'une série de 633 patients |
|
| Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study |
|
| SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment |
|
| There is no rational use of systematic post-operative CT-scanner after neurosurgical craniotomy. |
|
| TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma |
|
